Enzymotec Ltd. (ENZY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ENZY Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Enzymotec Ltd. finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2016)
0 0 0 (Dec 31 2015)
Assets
Cash & cash equivalent7.58
Marketable Securities, Current SH52.75
Cash & Short-term Investments59.00
Accounts receivable10.04
Nontrade Receivables, Current2.03
Inventories2.97
Other Current Assets41.67
Total loans net0.55
Total Current Assets80.91
Equipment/Property/Plant Net13.67
Long-term investments1.72
Defined Benefit Plan, Assets for Plan Benefits, Noncurrent DE1.14
Other Assets, Noncurrent0.00
Total Assets146.95
Liabilities
Accounts Payable5.13
Accrued Liabilities, Current0.14
Total Current Liabilities8.93
Total Long-term Debt0.00
Defined Benefit Pension Plan, Liabilities, Noncurrent PE1.42
Total Liabilities10.35
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock127.01
Retained Earnings / Accumulated Deficit9.96
Accumulated Other Comprehensive Income-0.47
Other Equity-0.44
Common Stockholder's Equity136.60
Total Stockholder's Equity136.60
Liabilities & Stockholder's Equity146.95
4 historic quarters locked

Sign in to unlock the full Enzymotec Ltd. balance sheet history.

About ENZY Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.